Drug Shortage Report for GABAPENTIN
Report ID | 207859 |
Drug Identification Number | 02353245 |
Brand name | GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | N02BF |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-23 |
Estimated end date | |
Actual end date | 2023-11-13 |
Shortage status | Resolved |
Updated date | 2023-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-11-14 | English | Compare |
v7 | 2023-11-13 | French | Compare |
v6 | 2023-11-13 | English | Compare |
v5 | 2023-11-06 | French | Compare |
v4 | 2023-11-06 | English | Compare |
v3 | 2023-10-24 | English | Compare |
v2 | 2023-10-23 | French | Compare |
v1 | 2023-10-23 | English | Compare |
Showing 1 to 8 of 8